Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults

BACKGROUND: When two or more vaccines are administered concurrently, there is concern about safety and immunogenicity from vaccine interaction. METHODS: Subjects aged ≥50 years were randomized 1:1:1 to receive tetanus-diphtheria (Td) + 13-valent pneumococcal conjugate vaccine (PCV13; Group 1), PCV13...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Joon Young, Cheong, Hee Jin, Noh, Ji Yun, Choi, Min Joo, Yoon, Jin Gu, Lee, Saem Na, Kang, Seong Hui, Jeong, Eun Joo, Jo, Yu Mi, Kim, Woo Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282243/
https://www.ncbi.nlm.nih.gov/pubmed/30518331
http://dx.doi.org/10.1186/s12879-018-3479-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282243/
https://www.ncbi.nlm.nih.gov/pubmed/30518331
http://dx.doi.org/10.1186/s12879-018-3479-9

Ejemplares similares